Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

GeoVax Labs, Inc. GOVXW NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
28/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

GeoVax Labs, Inc. (GOVXW) is a Biotechnology company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 27/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $4M, -89.5%/yr average growth. Net income is $25M (loss), growing at -19.1%/yr. Net profit margin is -632% (negative). Gross margin is 97.6% (+4037.6 pp trend).

Balance sheet: total debt is $0 against $5.0T equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 2.55 (strong liquidity). Debt-to-assets is 0%. Total assets: $8M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 0/100 (Fail), Health 67/100 (Partial), Moat 50/100 (Partial), Future ?/100 (Fail), Income 10/100 (Fail).

GOVXW SharesGrow Score Overview

36/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 50/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — GOVXW

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✗
GROWTH Fail
15/100
GOVXW: -89.5%/yr revenue is, -19.1%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
~
HEALTH Partial
67/100
Balance sheet GOVXW: Debt-to-Equity (D/E) ratio 0 (conservative), Current ratio is 2.55 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
50/100
GOVXW: Gross margin is 97.6% (+4037.6 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 50/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
GOVXW: Net profit margin is -632%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.0035-0.0054
Volume94.45K
Avg Volume (30D)16.33K
Market Cap$88.76K
Beta (1Y)3.57
Share Statistics
EPS (TTM)-4.82
Shares Outstanding$5.19M
IPO Date2020-09-25
Employees17
CEODavid Alan Dodd
Financial Highlights & Ratios
Revenue (TTM)$3.95M
Gross Profit$3.86M
EBITDA$-24.88M
Net Income$-24.99M
Operating Income$-25.14M
Total Cash$5.51M
Net Debt$-5.51M
Total Assets$8.16M
Price / Earnings (P/E)-0
Price / Sales (P/S)0.02
Analyst Forecast
Company Info
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS3736781192

Price Chart

Track all markets on TradingView
GOVXW
GeoVax Labs, Inc. ↗  ·  NASDAQ Capital Marke
Healthcare • Biotechnology
0.00 52WK RANGE 0.01

People Also View

ATNFW
ATNFW
CannBioRx Life Sciences Corp.
$0.43
-6.52%
 VRMEW
VRMEW
VerifyMe, Inc.
$0.01
-39.57%
 ARTLW
ARTLW
Artelo Biosciences, Inc.
$0.01
+0.00%
 BCDAW
BCDAW
BioCardia, Inc.
$0.01
-3.17%
 ENTXW
ENTXW
Entera Bio Ltd. WT EXP 062723
$0.00
-60.00%
 LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message